openPR Logo
Press release

Arthritis Monoclonal Antibodies Market Report 2024 - Arthritis Monoclonal Antibodies Market Size, Share And Trends

11-25-2024 07:54 AM CET | Health & Medicine

Press release from: The Business research company

Arthritis Monoclonal Antibodies Market

Arthritis Monoclonal Antibodies Market

"The Business Research Company recently released a comprehensive report on the Global Arthritis Monoclonal Antibodies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, The arthritis monoclonal antibodies market size has grown strongly in recent years. It will grow from $58.09 billion in 2023 to $62.29 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to rising prevalence of arthritis, increasing awareness of arthritis monoclonal antibodies, expanding range of approved arthritis monoclonal antibodies, government support for research and development, increased investment from pharmaceutical companies.

The arthritis monoclonal antibodies market size is expected to see strongly grown in the next few years. It will grow to $83.76 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to combination therapies, expanding indications, patient preference, increased healthcare spending. Major trends in the forecast period include biosimilars and biobetters, targeted therapies, homecare administration, real-world evidence, cost and access considerations, advancements in drug delivery.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report

Market Drivers and Trends:
The increasing prevalence of arthritis globally has contributed to the growth of the arthritis monoclonal antibody market. According to the Global RA Network, in 2021, Over 350 million individuals worldwide suffer from arthritis and osteoarthritis is the most common form of arthritis followed by gout, fibromyalgia, and rheumatoid arthritis. According to WHO, the prevalence of rheumatoid arthritis varies between 0.3% and 1%, and the worldwide estimates of osteoarthritis include 9.6% of men and 18% of women. The increased prevalence of arthritis and the demand for personalized medicine are increasing the demand for the market.

The development of therapeutic monoclonal antibody products is becoming an indispensable tool in the development of the arthritis monoclonal antibody market. Monoclonal antibodies are more efficient than small molecules and peptides in the treatment of arthritis. These are target-specific and have good efficiency for disease treatment. These improved treatment options are evident with the launch of a greater number of monoclonal antibody drugs for arthritis.

Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=3449&type=smp

Major Key Players of the Market:
Johnson & Johnson; Hoffmann-La Roche Ltd.; Novartis AG; Pfizer Inc.; AbbVie Inc.; Amgen Inc.; Genentech Inc.; GlaxoSmithKline plc.; AstraZeneca plc; Mylan N.V.; Bristol Myers Squibb; Eli Lilly and Company; Thermo Fisher Scientific Inc.; Sanofi SA; Novo Nordisk A/S; Daiichi Sankyo Company Ltd.; Seattle Genetics; Teva Pharmaceutical Industries Ltd.; Shanghai Junshi Biosciences Co. Ltd.; GenScript Biotech Corporation; Sigma-Aldrich Co. LLC; AbGenomics Corp.; ADC Therapeutics SA; Agensys Inc.; Alexion Pharmaceuticals Inc.; ALMAC Group Ltd.; Ambrx Inc.; Astellas Pharma Inc.; Celgene Corporation; Celldex Therapeutics Inc.; Boehringer Ingelheim International GmbH; Celltrion Inc.; HanAll Biopharma Co. Ltd.; Merck & Co. Inc.; Mitsubishi Tanabe Pharma Corporation; Regeneron Pharmaceuticals Inc.; Samsung Bioepis Co. Ltd.

Arthritis Monoclonal Antibodies Market 2024 Key Insights:
• The arthritis monoclonal antibodies market size will grow to $83.76 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%.
• Arthritis Prevalence Fuels Growth In Arthritis Monoclonal Antibody Market
• Advancements In Therapeutic Monoclonal Antibodies Revolutionize The Arthritis Treatment Landscape
• North America was the largest region in the arthritis monoclonal antibodies market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=3449&type=smp

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Arthritis Monoclonal Antibodies Market Report 2024 - Arthritis Monoclonal Antibodies Market Size, Share And Trends here

News-ID: 3753340 • Views:

More Releases from The Business research company

Global Surge In Air Pollution Propels Growth In The Industrial Air Filtration Market: Transformative Forces Shaping the Industrial Air Filtration Market Landscape in 2025
Global Surge In Air Pollution Propels Growth In The Industrial Air Filtration Ma …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Industrial Air Filtration Industry Market Size Be by 2025? Over the past several years, the industrial air filtration market has seen robust growth. Expected to increase from $14.97 billion in 2024 to $15.79 billion in 2025, it will experience a compound annual growth rate (CAGR) of
Steady Expansion Forecast for Heavy Construction Equipment Market, Projected to Reach $278.14 Billion by 2029
Steady Expansion Forecast for Heavy Construction Equipment Market, Projected to …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Heavy Construction Equipment Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size of heavy construction equipment has seen significant expansion in the past few years. The market, which is expected to rise from $204.24 billion in 2024 to $215.46 billion in 2025, will
Form-Fill-Seal Equipment Industry Outlook 2025-2029: Market Set to Cross $23.82 Billion Milestone
Form-Fill-Seal Equipment Industry Outlook 2025-2029: Market Set to Cross $23.82 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Form-Fill-Seal Equipment Market Size By 2025? The market for form-fill-seal equipment has experienced gradual expansion in recent times. It's projected to rise from $17.81 billion in 2024 to $18.62 billion in 2025, with a compound annual growth rate (CAGR) of 4.5%. The growth in previous
Top Market Shifts Transforming the Filtration & Drying Equipment Market Landscape: Key Insights
Top Market Shifts Transforming the Filtration & Drying Equipment Market Landscap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Filtration & Drying Equipment Market Through 2025? Recent years have seen a robust increase in the size of the filtration & drying equipment market. Forecasts show a market rise from $1.94 billion in 2024 to $2.06 billion in 2025, with a Compound

All 5 Releases


More Releases for Arthritis

Rising Arthritis Cases Fueling Market Growth For Rheumatoid Arthritis Drugs: Piv …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Rheumatoid Arthritis Drugs Market Size Growth Forecast: What to Expect by 2025? In recent years, there has been a slight decline in the rheumatoid arthritis drugs market size. It is projected to rise from "$60.3 billion in 2024 to $60.1 billion in 2025, with a compound annual growth rate
Infectious Arthritis (Septic Arthritis) Market Detailed Industry Report Analysis …
Introduction Infectious arthritis, also known as septic arthritis, is a serious joint condition caused by bacterial, viral, or fungal infections that lead to rapid joint destruction if not treated promptly. The disease primarily affects large joints such as the knee and hip but can also impact smaller joints. It is considered a medical emergency requiring rapid diagnosis and treatment with antibiotics or antifungals, often combined with joint drainage or surgical intervention. The
Nooro Arthritis Hand Massager Reviews: Is the Nooro Arthritis Hand Massager Wort …
The Nooro Arthritis Hand Massager is a revolutionary device designed to offer relief to individuals suffering from hand pain, particularly those dealing with conditions such as arthritis, carpal tunnel syndrome, and repetitive strain injuries. As hand pain can significantly impact daily activities, from typing to gripping objects, finding an effective, non-invasive solution is crucial. The Nooro Arthritis Hand Massager provides a gentle yet effective remedy by combining advanced heat therapy
Rheumatoid Arthritis Drug Market Rheumatoid Arthritis Clinical Pipeline Report 2 …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Antirheumatoids: Call of Rheumatoid Arthritis 1.1 Prologue towards Rheumatoid Arthritis 1.2 Obtainable Treatment for Rheumatoid Arthritis Molecular Mechanism of Antirheumatoids 2.1 Purpose of DMARDs in Rheumatoid Arthritis 2.2 Role of Biological Agents in Rheumatoid Arthritis 2.2.1 TNF- Inhibitors 2.2.2 Interleukin -1 and IL-6 Blockers Classification of Rheumatoid Arthritis Drugs 3.1
Rheumatoid Arthritis Treatment Market
Rheumatoid arthritis (RA) is the most common autoimmune arthritis affecting more than 1.3 million U.S. citizens (American College of Rheumatology). More surprising is to know that around 75% of this affected population is women. Affecting the joints at any age, rheumatoid arthritis needs to be addressed early to avoid expensive joint replacement surgery. While it can affect any joint, small joints in hand and feet tend to be affected the
Worldwide Arthritis - EpiCast Report: Rheumatoid Arthritis - Epidemiology Foreca …
"EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2025" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- ** Summary Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the bodys immune system attacks the lining of the joints, known as